Found: 8
Select item for more details and to access through your institution.
Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
- Published in:
- Clinical & Experimental Nephrology, 2003, v. 7, n. 2, p. 120, doi. 10.1007/s10157-003-0222-6
- By:
- Publication type:
- Article
CLINICAL NEPHROLOGY - EPIDEMIOLOGY - CLINICAL TRIALS Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy.
- Published in:
- Kidney International, 2004, v. 65, n. 2, p. 621, doi. 10.1111/j.1523-1755.2004.00419.x
- By:
- Publication type:
- Article
Supplementary data to the study of ESRD Map in Japan.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.
- Published in:
- Kidney International, 2003, v. 64, n. 4, p. 1445, doi. 10.1046/j.1523-1755.2003.00221.x
- By:
- Publication type:
- Article
Prevalence of Alzheimer's disease with diabetes in the Japanese population.
- Published in:
- Psychogeriatrics, 2008, v. 8, n. 2, p. 73, doi. 10.1111/j.1479-8301.2008.00229.x
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Represents a Promising Treatment Modality for Diabetic Encephalopathy.
- Published in:
- Diabetes, 2007, v. 56, p. A507
- By:
- Publication type:
- Article
Insulin Protection Against Carbonyl and Hyperglycemic Stress-induced Neuronal Cell Apoptosis.
- Published in:
- Diabetes, 2007, v. 56, p. A345
- By:
- Publication type:
- Article
Insulin Confers Neuroprotection Against Hyperglycemic Stress-Induced Apoptosis Through PI3K/Akt/mTOR/Nrf2/GCL/Redox Signaling.
- Published in:
- Diabetes, 2007, v. 56, p. A169
- By:
- Publication type:
- Article